About Technology Issues FAQ

Links

Multicentre phase II study of imatinib mesylate in patients with recurrent glioblastoma: An EORTC: NDDG/BTG Intergroup Study

Multicentre phase II study of imatinib mesylate in patients with recurrent glioblastoma: An EORTC: NDDG/BTG Intergroup Study — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.